A Microgel Platform Enables Site‐Specific Intestinal Delivery of Lactoferrin, Improving its Bioavailability for Targeted Alleviating Liver Injury and Colitis
Advanced Science · 2026-08 · 13 (45)
DOI: 10.1002/advs.75697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.05.2026. Verfasst von Huiling Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China. Hauptthemen laut MEDLINE: Lactoferrin, Microgels, Colitis, Drug Delivery Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Pin-duo-duo China Agricultural University Research Fund.
Abstract (Originalsprache)
Oral delivery of bioactive proteins remains a challenging area, as it demands effective gastric protection and intestinal site‐specific release. We design two intestinal site‐specific microgels via Fe 3 + ‐COO − coordination or STMP‐conjugated cross‐linking of eco‐friendly and biocompatible Artemisia sphaerocephala Krasch. polysaccharides (ASKP) extracted from desert sand‐fixing plant; these microgels release lactoferrin (Lf) precisely in the small intestine or colon on‐demand. Both microgels protect Lf from gastric digestion, preserve the Lf receptor (LfR)‐binding domain, and facilitate efficient LfR‐mediated endocytosis of Lf by intestinal epithelial cells. Small intestine‐targeted microgels regulate Lf metabolism, boost Lf bioavailability by ≈6‐fold, and drive marked hepatic Lf accumulation. These effects ameliorate alcoholic liver injury via the Nrf2‐mediated antioxidant pathway and CPT1A‐amplified fatty acid β‐oxidation after oral uptake. Colon‐targeted microgels alleviate ulcerative colitis by suppressing the TLR4/MyD88/NF‐κB inflammatory axis and restoring gut microbiota homeostasis. Notably, this is the first demonstration of site‐specific intestinal delivery achieved by using different cross‐linking chemistries on the same ASKP backbone, enabling distinct gut‐regional specific therapeutic actions. This work establishes food‐grade microgel platforms as promising intestinal site‐specific delivery systems for spatiotemporally controlled, on‐demand delivery of bioactive proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China.
- Research Center of Food Colloids and Delivery of Functionality, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
- Division of Food Quality and Design, Wageningen University and Research, Wageningen, Netherlands.
- School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
- Liggins Institute, University of Auckland, Auckland, New Zealand.
ORCID-Profile: Yuan Li
Förderung
- National Key Research and Development Program of China
- Pin-duo-duo China Agricultural University Research Fund
Zitieren
APA
Yan, H., Li, Y., Chen, S., Du, P., Wu, K., Zhang, H., Hettinga, K., Zhang, L., Toldi, G., Ren, F., & Li, Y. (2026). A Microgel Platform Enables Site‐Specific Intestinal Delivery of Lactoferrin, Improving its Bioavailability for Targeted Alleviating Liver Injury and Colitis. Advanced Science, 13(45). https://doi.org/10.1002/advs.75697
Vancouver
Yan H, Li Y, Chen S, Du P, Wu K, Zhang H, et al. A Microgel Platform Enables Site‐Specific Intestinal Delivery of Lactoferrin, Improving its Bioavailability for Targeted Alleviating Liver Injury and Colitis. Advanced Science. 2026;13(45). doi:10.1002/advs.75697
BibTeX
@article{Yan2026,
author = {Yan, Huiling and Li, Yixuan and Chen, Shanan and Du, Pengcheng and Wu, Kaiwen and Zhang, Hui and Hettinga, Kasper and Zhang, Lina and Toldi, Gergely and Ren, Fazheng and Li, Yuan},
title = {A Microgel Platform Enables Site‐Specific Intestinal Delivery of Lactoferrin, Improving its Bioavailability for Targeted Alleviating Liver Injury and Colitis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {45},
doi = {10.1002/advs.75697}
}
EUVIMED